Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06540885

A Comparison Between Palonosetron Versus Granisetron as PONV Prophylaxis in Scoliotic Patients Undergoing Spine Surgery (PONV)

A Comparison Between Palonosetron Versus Granisetron As Postoperative Nausea and Vomiting Prophylaxis In Idiopathic Scoliosis Surgery: A Randomized Control Trial

Sponsor: University of Malaya

Conditions Postoperative Nausea and Vomiting Scoliosis

Interventions Granisetron (Group G) Palonosetron (Group P)

Updated 3 times since 2024 Last updated: Apr 22, 2025 Started: Jan 6, 2025 Primary completion: Jul 31, 2026 Completion: Sep 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Postoperative Nausea and Vomiting and Scoliosis and is currently actively recruiting participants. University of Malaya leads this study, which shows 3 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

May 2025 — Present [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Jan 2025 — May 2025 [monthly]

Not Yet Recruiting PHASE4
Sep 2024 — Jan 2025 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Malaya

Data source: University of Malaya

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kuala Lumpur, Malaysia
• Pantai Valley, Malaysia